In-Vitro Colorectal Cancer Screening Tests Market to Gain Commendable Proceeds Over 2021-2025

The in-vitro colorectal cancer screening tests market forecast will be potentially driven by the high risks of acquiring colorectal cancer. Developing chronic conditions like obesity, inflammatory bowel disease, and type 2 diabetes owing to the adoption of sedentary lifestyles, and improved diagnostics tests will further promote the industry trends.

There is a significant use of molecular screening and DNA testing along with a shift from individual gene testing to whole genome or exome sequencing for evaluating at-risk individuals for inherited colorectal cancer. It has been reported that global in-vitro colorectal cancer screening tests market size world-wide is likely to surpass USD 1.3 billion by 2025.

Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/451

Fecal occult blood tests (FOBT) come as a cost-effective diagnostic option. In 2018, the FOBT segment controlled almost 83.8% of the entire market revenue share. Furthermore, the segment is estimated to record a CAGR of 4.7% within 2025. Increasing sensitivity and specificity of stool-based tests could enhance the adoption of FOBTs in the future. 

A fecal occult blood test is often considered as an early screening test for colorectal cancer. It is employed to analyze other conditions that lead to bleeding in the digestive tract. In fact, the National Cancer Institute advises people aged above 50 to regularly perform screenings for colorectal cancer.

Rising presence of geriatric population supported by increasing susceptibility of the elderly to contract colorectal diseases could stimulate the demand for in-vitro colorectal cancer screening tests across North America. In-vitro colorectal cancer screening tests industry is also gaining steady traction across Europe. Research suggest that the market in Europe could register a compound annual growth rate of 5% by the end of 2025.

Geographically, North America in-vitro colorectal cancer screening tests market will expand with the rapidly rising geriatric population and susceptibility of the elderly population to acquire the diseases. The market share for Europe was calculated at USD 337.4 million in 2018 and is anticipated to register a CAGR of 5% up to 2025.

Prominent industry players like Abbott Molecular, Siemens Healthcare, Qiagen, EMD Millipore, Beckman Coulter, Eiken Chemical, and Alere are concentrating on innovative research and development projects to create advanced tests that would be able to deliver precise results instantly.

Request for a Customization of this research report @ https://www.decresearch.com/roc/451

Partial Chapter of the Table of Content

Chapter 4. In-Vitro Colorectal Cancer Screening Tests Market, By Test Type

4.1. Key segment trends

4.2. Fecal occult blood test (FOBT)

4.2.1. In-Vitro Colorectal Cancer Screening Tests Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.2.2. Guaiac FOB stool test

4.2.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.2.3. Immuno-FOB agglutination test

4.2.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.2.4. Lateral flow immuno-FOB test

4.2.4.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.2.5. Immuno-FOB ELISA test

4.2.5.1. In-Vitro Colorectal Cancer Screening Tests Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.3. Biomarker test

4.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.3.2. Tumor M2-PK stool test

4.3.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.3.3. Transferrin assays

4.3.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.4. CRC DNA screening test

4.4.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.4.2. Methylated gene test

4.4.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.4.3. Panel DNA test

4.4.3.1. In-Vitro Colorectal Cancer Screening Tests Market estimates and forecast, by region, 2014 - 2025 (USD Million)

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/in-vitro-colorectal-cancer-screening-tests-market-report